机译:Current and emerging biologic therapies for triple negative breast cancer
Dept Med,Univ Pittsburgh;
Breast cancer; immunotherapy; metastatic; neoadjuvant; targeted therapy; TUMOR-INFILTRATING LYMPHOCYTES; CELL-TRANSFER THERAPY; RANDOMIZED PHASE-II; T-CELLS; SACITUZUMAB GOVITECAN; 1ST-LINE THERAPY; ANTIBODY; CARBOPLATIN; IMMUNOTHERAPY; CHEMOTHERAPY;